Table 3.
Journals | Paper number | Top-Paper number | Top-Paper rate b | Total citation | Citation per paper | Citation per paper per year | Local citation c | IF (2021) |
---|---|---|---|---|---|---|---|---|
N. Engl. J. Med. | 5 | 5 | 100.00% | 6269 | 1253.80 | 191.09 | 8423 | 176.08 |
Lancet | 7 | 6 | 85.71% | 3635 | 519.29 | 75.47 | 3070 | 202.73 |
Lancet Oncol. | 29 | 9 | 31.03% | 7461 | 257.28 | 41.57 | 4248 | 54.43 |
JAMA Oncol. | 24 | 2 | 8.33% | 1846 | 76.92 | 24.80 | 926 | 33.01 |
J. Clin. Oncol. | 153 | 29 | 18.95% | 24346 | 159.12 | 15.08 | 23597 | 50.72 |
JNCI | 14 | 3 | 21.43% | 2034 | 145.29 | 10.38 | 1815 | 11.82 |
J. Nucl. Med. | 39 | 3 | 7.69% | 3005 | 77.05 | 9.39 | 1734 | 11.08 |
Clin. Chest Med. | 9 | 1 | 11.11% | 933 | 103.67 | 9.36 | 171 | 4.97 |
Radiology | 14 | 1 | 7.14% | 1199 | 85.64 | 8.49 | 1952 | 29.15 |
Cancer Res. | 29 | 2 | 6.90% | 2993 | 103.21 | 7.84 | 4996 | 13.31 |
Only journals with at least five papers related to lung cancer radiotherapy were included.
Percentage of top- papers among all papers in a journal. The time span was from 2010 to 2019 (the publication year of the lastest top- paper).
Citation number in the current dataset (papers in lung cancer radiotherapy from 2000 to 2022).